Recombinant multi-species IL-29/IFNL1/IL29 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-29/IFNL1/IL29 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 28B (IL28B) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). [provided by RefSeq, Jul 2008]
The Alternative Names of target: Cytokine Zcyto21,IFN-lambda-1,IFNL1,IL-29,IL29,Interferon lambda-1,Interleukin-29 (IL-29)

Target products collectionGo to IL-29/IFNL1/IL29 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T78381-Ag-1/ GM-Tg-hg-T78381-Ag-2 Human IL-29/IFNL1/IL29 protein Human
GM-Tg-rg-T78381-Ag-1/ GM-Tg-rg-T78381-Ag-2 Rat IL-29/IFNL1/IL29 protein Rat
GM-Tg-mg-T78381-Ag-1/ GM-Tg-mg-T78381-Ag-2 Mouse IL-29/IFNL1/IL29 protein Mouse
GM-Tg-cynog-T78381-Ag-1/ GM-Tg-cynog-T78381-Ag-2 Cynomolgus/Rhesus macaque IL-29/IFNL1/IL29 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T78381-Ag-1/ GM-Tg-felg-T78381-Ag-2 Feline IL-29/IFNL1/IL29 protein Feline
GM-Tg-cang-T78381-Ag-1/ GM-Tg-cang-T78381-Ag-2 Canine IL-29/IFNL1/IL29 protein Canine
GM-Tg-bovg-T78381-Ag-1/ GM-Tg-bovg-T78381-Ag-2 Bovine IL-29/IFNL1/IL29 protein Bovine
GM-Tg-equg-T78381-Ag-1/ GM-Tg-equg-T78381-Ag-2 Equine IL-29/IFNL1/IL29 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T78381-Ag-1/ GM-Tg-hg-T78381-Ag-2; GM-Tg-rg-T78381-Ag-1/ GM-Tg-rg-T78381-Ag-2;
GM-Tg-mg-T78381-Ag-1/ GM-Tg-mg-T78381-Ag-2; GM-Tg-cynog-T78381-Ag-1/ GM-Tg-cynog-T78381-Ag-2;
GM-Tg-felg-T78381-Ag-1/ GM-Tg-felg-T78381-Ag-2; GM-Tg-cang-T78381-Ag-1/ GM-Tg-cang-T78381-Ag-2;
GM-Tg-bovg-T78381-Ag-1/ GM-Tg-bovg-T78381-Ag-2; GM-Tg-equg-T78381-Ag-1/ GM-Tg-equg-T78381-Ag-2
Products Name IL-29/IFNL1/IL29 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IL-29/IFNL1/IL29
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-29/IFNL1/IL29 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.